Inventor
MOLHOJ MICHAEL
DE27 patents
⚠️ This page may combine multiple inventors who share the name “MOLHOJ MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
23 patentsUS9914776B2Mar 13, 2018
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE16 citations92
US11603411B2Mar 14, 2023
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE9 citations85
US11286300B2Mar 29, 2022
Humanized anti-human CD19 antibodies and methods of use
HOFFMANN LA ROCHE11 citations85
US10941205B2Mar 9, 2021
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE10 citations85
US10611840B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US10611841B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US10822402B2Nov 3, 2020
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US9862763B2Jan 9, 2018
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US11117965B2Sep 14, 2021
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE2 citations73
US11787868B2Oct 17, 2023
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE1 citations72
US10538585B2Jan 21, 2020
Anti-ANG2 antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US10730938B2Aug 4, 2020
Bispecific antibodies and methods of use in ophthalmology
HOFFMANN LA ROCHE3 citations71
US11958912B2Apr 16, 2024
Method for determining the in vivo interaction mode
HOFFMANN LA ROCHE2 citations70
US12358997B1Jul 15, 2025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies
HOFFMANN LA ROCHE0 citations62
US12297263B2May 13, 2025
Humanized anti-Tau(PS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US12215152B2Feb 4, 2025
Humanized anti-human CD19 antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US12030952B2Jul 9, 2024
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE1 citations62
US11572404B2Feb 7, 2023
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US10766967B2Sep 8, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE1 citations62
US11486882B2Nov 1, 2022
Method for detecting multispecific antibody light chain mispairing
HOFFMANN LA ROCHE2 citations61
US12522653B2Jan 13, 2026
Antibody that binds to VEGF-A and ANG2 and methods of use
HOFFMANN LA ROCHE0 citations59
US12287335B2Apr 29, 2025
Direct affinity measurement of human IgG1 binding multimeric antigens
HOFFMANN LA ROCHE0 citations59
US11732036B2Aug 22, 2023
Antibody that binds to VEGF-A and ANG2 and methods of use
HOFFMANN LA ROCHE0 citations59